CMO / CDMO Partnership

Turn manufacturing expertise into U.S. market wins, without building a commercial arm of your own. For more than a decade, Terrain has partnered with contract manufacturers on every link of the product journey - formulation, scale-up, validation, launch, and lifecycle management - across North America, Europe, India, and Asia. We pair your production capabilities with our proven regulatory playbooks, capital support, and nationwide channel network so that scale translates to sales.

Why Contract Manufacturers Partner With Terrain

Your Objective

Enter the U.S. Market

How We Add Value

Flow-optimized semisolid design and custom hydrogel / DIA matrix engineering

Your Objective

Secure Demand for New Capacity

How We Add Value

Long-term supply agreements tied to our 6,000-prescriber network and national channels lock in forecastable volume; historical launch data lets you size batches with confidence.

Your Objective

Co-Develop and Share Upside

How We Add Value

Flexible JV, milestone, or royalty models fund formulation, clinical, and launch work so risk and reward are shared exactly as we’ve done with partners on patches, gels, ointments, and oral solids.

Your Objective

Upgrade Operations

How We Add Value

Capital injections for equipment, automation, and analytical upgrades, plus Terrain quality oversight to speed validation, leveraging our experience executing multi-site tech transfers without line downtime.

How We Work Together

Regulatory & Market Assessment
  • Pathway mapping (505(b)(2), ANDA, OTC monograph, etc.)
  • Competitive landscape & price corridor
  • Go / No-Go and time-to-value model
Commercial Blueprint
  • Channel mix (wholesale, physician-dispensed, digital Rx)
  • Forecast & launch inventory plan
  • Pricing, chargeback, and compendia set-up
Technology Transfer
& Scale-Up
  • Detailed tech-pack, validation protocols, and quality alignment
  • Automation or analytical upgrades funded through milestone tranches
  • Phased volume ramp with Terrain engineers on-site at critical runs, drawing on our track record of 10+ successful transfers on three continents
Growth, Line Extension, or Liquidity
  • New strengths, pack sizes, or platform migrations to extend lifecycle
  • Option for Terrain purchase or royalty buy-out of mature assets

Partnership Toolkit

Extensive CMO Experience

Flow-optimized Collaborative history with sterile, non-sterile, topical, transdermal, and oral dose manufacturers means we possess deep knowledge of site capabilities, audit expectations, and cultural nuances. id design and custom hydrogel / DIA matrix engineering

Regulatory Expertise

Dossier authoring, FDA meeting management, SPL & listing, change-control strategy.

Commercial Access

6,000-prescriber physician channel, digital pharmacies, and specialty wholesalers for coast-to-coast reach.

Capital & Capacity

Equipment financing, scale-up grants, and infrastructure build-outs tied to volume commitments.

Operational Excellence

Process optimization, automation support, and audit-ready quality oversight.

Risk Mitigation

Phased implementation, technical troubleshooting, and guaranteed off-take volumes.

At-A-Glance Benefits

U.S. launch in a fraction of the usual time and cost

Guaranteed demand to justify capacity expansion

Shared-risk co-development so that no single party carries the entire load

Continuous improvement and quality alignment to global standards backed by years of hands-on CMO collaboration